GlobeNewsWire
13 Nov 2025, 14:22 UTC · 43w ago
Verdict
Headline takes no side. We score IVA +0.40 across three claims — moderately bullish.
+0.40moderately bullish
More positive than 66% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
The company expects to raise approximately $140.1 million in net proceeds, potentially increasing to $161.2 million if the underwriters' option is fully exercised.
So whatA significant cash infusion provides a critical runway for a clinical-stage biopharmaceutical company to fund R&D and operations.
More positive than 85% of claims this week
Inventiva has priced a public offering of approximately 39 million new American Depositary Shares (ADSs) at $3.85 per share.
So whatThe issuance of a large volume of new shares creates immediate equity dilution for existing shareholders.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 80% of claims this week
The offering price of $3.85 represents a discount of 0.89% relative to the volume-weighted average price on Euronext for the preceding trading session.
More negative than 62% of claims this week
Which stocks this story touches
More positive than 66% of ticker scores this week
The company is successfully raising approximately $150M in capital through an upsized public offering to fund its clinical-stage operations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
4h ago
−4.7%
Price is moving against the score
$3.86 vs $4.05 close before publication (Nov 12) · not market-adjusted
IVA chart →
